Oleoyl-estrone lowers the body weight of both ob/ob and db/db mice

Horm Metab Res. 2000 Jun;32(6):246-50. doi: 10.1055/s-2007-978629.

Abstract

Homozygous obese db/db (BKS-Lepr(db) and ob/ob (B6-Lep(ob)) mice were treated for 14 days with a continuous infusion of a fat emulsion (controls) or loaded with oleoyl-estrone at doses of 12.5 and 50 nmol/g x d using surgically inserted osmotic minipumps. Treatment with oleoyl-estrone resulted in a marked decrease in body weight in both strains, compared with the unchecked growth of controls. In db/db mice, plasma urea and insulin, as well as liver lipid decreased with treatment. In ob/ob mice, the effect on insulin was more marked, in parallel with higher plasma lipids pointing to increased fat mobilisation. The results suggest that oleoyl-estrone effects on body fat reserves and insulin resistance are not mediated by leptin, since ob/ob mice lack this hormone and in the db/db it is present but cannot induce effects because of defective leptin receptors; in both cases oleoyl-estrone treatment lowers body weight.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Obesity Agents / pharmacology*
  • Body Weight / drug effects*
  • Estrone / analogs & derivatives*
  • Estrone / pharmacology
  • Female
  • Insulin / blood
  • Lipids / blood
  • Mice
  • Mice, Obese
  • Oleic Acids / pharmacology*

Substances

  • Anti-Obesity Agents
  • Insulin
  • Lipids
  • Oleic Acids
  • Estrone
  • oleoyl-estrone